Daily news email for April 23, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
3rd International Definiens Symposium to be Held in Munich from June 14-16, 2012

Labor L+S AG and SYMBIOSIS Form Exclusive Business Alliance

Better Prevention of Transmission and Lesion Development of Genital Herpes Predicted for ...

ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research

Human Cell Technology Company Medicyte Awarded ISO 9001 Certification

BioSpace
China Cord Blood Corporation Announces $65 Million Investment from Kohlberg Kravis Roberts & Co. L.P.

Pharmaceutical Education and Research Institute (PERI): Biopharma Injected $49.5 Billion in R&D Last Year

Hyperion Therapeutics Files for $58 Million US IPO

Sanofi (France) CEO: Hub's Life Sciences Lead at Risk, Calls for Alliances to Solve Scientic Problems

Left Hand Right Hand, Premature Babies Make the Link, Centre National de la Recherche Scientifique Study

BioSpace - Breaking News
Bristol-Myers Squibb Company Release: Investigational Compound Peginterferon Lambda Achieved SVR24 Rates Comparable to Peginterferon Alfa with Fewer Flu-Like and Musculoskeletal Symptoms in Phase IIb Study in Treatment-Nave Genotype 2 or 3 Hepatitis C Patients

Bristol-Myers Squibb Company Release: All-Oral Hepatitis C Virus Treatment with Bristol-Myers Squibb's Investigational Compounds Daclatasvir and Asunaprevir Achieved Sustained Virologic Response in 77% of Difficult-to-Treat Patients

Merck & Co., Inc. Reports Phase III Study Results Evaluating Anemia Management Strategies Used With VICTRELIS (boceprevir) Combination Therapy

Merck & Co., Inc. Release: Study Evaluating Anemia Management Strategies Used with VICTRELIS(TM) (boceprevir) Presented at Conference

Janssen Pharmaceutica N.V. Creates New Division to Launch TMC435 and Help Conquer Hepatitis C in EMEA

Biotech News - Business Wire
Aggredyne Closes $3 Million Series A Financing

Landec Corporation Acquires GreenLine Foods, Inc.

SD Biotech Association Expands Event for Researchers

Shareholder Update Regarding Capsalus Revenue Reporting Delay on Fiscal 2011 10-K Annual Report

Carl Vause Appointed Vice President of Marketing for OmniGuide, Inc.

Biotech News - PR Newswire
Thomson Reuters führt umweltwissenschaftlichen Partner Ecosystem ein, um Gemeinschaftlich R&D Arzneimittelprozesse voranzutreiben

Thomson Reuters lance son écosystème de partenaires en sciences de la vie pour la collaboration dans les processus de recherche et de développement de nouveaux médicaments

New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer

Generex Announces Date of Annual Stockholders' Meeting

Chiltern Announces New Legal Entity In Taiwan

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
NICE Rejects Avastin for Breast Cancer

Health IT Deals Hot in Q1

GlaxoSmithKline Steers toward Innovation

Survey: One in Four Americans Had a Gap in Healthcare Coverage in 2011

The May 2012 Issue of The Burrill Report

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
Interactive ORLive Program Discusses Cutting Edge Knee Surgery

New SEEDS Suppliers Added to Premier's Neonatal Developmental and Specialty Products Agreement Portfolio

Moberg Derma AB: Moberg Derma Interim Report January - March 2012

Ariosa Diagnostics Selects DSG as EDC Provider

NTRR Begins Clinical Trials of Enhanced Weight-Loss Formula

Clinical Trials - PR Newswire
Protein prevents DNA damage in the developing brain and might serve as a tumor suppressor

Boston Scientific Completes Enrollment in Clinical Trial to Evaluate Lotus Aortic Valve System

National Parkinson Foundation's Landmark Quality Improvement Initiative Enrolls 5,000 Parkinson's Patients

Oligomerix, Inc. Completes $2 Million Series A Financing

XEOMIN® (incobotulinumtoxinA) Data to be Presented at the 64th Annual Meeting of the American Academy of Neurology

CNN Top Stories
More U.N. monitors expected in Syria

Agents' boss survives scandal -- so far

Basement search comes up empty in Etan Patz case

Zelizer: Next president's hands tied

Frum: The Obama vs. Romney dogfight

Contract Pharma
New CEO for Quintiles

Harlan, Ipsen in Early Stage Services Pact

Pfizer To Sell Infant Nutritionals

Parexel COO Wins APCR Honor

AZ To Buy Ardea

FDA Drugs- What's New
FDA Drug Safety Communication: New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)

FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para Celexa (citalopram bromhidrato) relacionadas con el riesgo potencial de ritmo cardiaco anormal con dosis altas

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

FDA News - Business Wire
Medgenics Files for U.S. Orphan Drug Designation for INFRADURE for the Treatment of Hepatitis D

Phase IV Clinical Trials Outsourcing Booming to Meet Larger Goals, Finds Cutting Edge Information

Nearly Half of U.S. Adults Are Unaware of Recommended Vaccinations, Walgreens Survey Suggests

ViaValve Safety I.V. Catheter Receives 510(k) Clearance from the U.S. Food and Drug Administration

Samenvatting: Biogen Idec presenteert nieuwe data op American Academy of Neurology vergadering over veelbelovend therapieën voor neurologische ziekten

FDA Press Releases
FDA strengthens international collaboration to ensure quality, safety of imported products

Report: FDA strengthens monitoring of post-approval drug safety

U.S. Marshals seize ultrasound gel product at a New Jersey company

Application

CFP Online Application

FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

FierceBiotech
Pike picked to sit at Quintiles peak

Buzz: Amylin brings in the bankers to spur an auction

AstraZeneca reels in promising Phase III gout drug in $1.26B Ardea buyout

Biotech VC deals, dollars shrivel in Q1 as devices see an upturn

AstraZeneca reels in promising PhIII gout drug in $1.26B Ardea buyout

FierceBiotech IT
FierceBiotech IT in Boston this week

NextBio moves genetic analysis software into clinical R&D territory

Survey: Pharma lags peers in gaining trust via social media

GAO report: FDA's IT modernization 'in jeopardy'

Updated: Virtual MS research community emerges

FierceBiotech Research
Nanotech-boosted drug lessens cerebral palsy symptoms in rabbits

Scientists successfully replicate synthetic DNA

German scientists generate nerve cells directly from skin/umbilical cells

Surging research in Asia is an opportunity for us

UCLA morphs stem cells into T-cell missiles that seek and destroy HIV

FiercePharma
China sweeps up dozens in whirlwind drug-capsule probe

Novartis blueprints $550M Swiss drug plant after layoffs backlash

Pfizer gets $11.85B in nutrition sale to Nestlé

Amylin's up for bid. Who'll step in line

FDA warns 56 more docs of fake Avastin supplies

FiercePharma Manufacturing
UPDATED: U.S. Marshals seize ultrasound gel containing dangerous levels of bacteria

Incentives entice Mylan to expand in Ireland

GAO hammers FDA for not updating IT system, using faulty system to track foreign drugmakers

J&J plant overhaul turning into 4-year project

CSL recalling product tainted with ethylene glycol

FierceVaccines
Passive vaccine could treat cocaine overdose

Scancell's DNA melanoma vaccine poised for Phase II

Taiwan's RSV vaccine heads toward the clinic

Personalized brain cancer vaccine improves survival

Roche collaborating over AIDS vaccine; TapImmune has licensed cancer antigen;

Health News - BizJournals.com
What are the hottest jobs in Cincinnati health care

Companies from various sectors enter social media contest

Christian Care Communities breaks ground on renovation in Bowling Green

Union plans strike at 10 Sutter hospitals

Child and elder care marketplace Care.com expands to UK

Health News - CNBC
HeartWare shares up as FDA safety review minimized

Amylin Explores Sale, Hires Bankers: Sources

FDA staff concerned with HeartWare device safety

AstraZeneca buying Ardea in $1.26 bln deal

Nestle wins pricey battle for Pfizer baby food unit

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
BTG Reports Positive Results from Second Phase III Varicose Veins Study

Oligomerix Raises $2M for Tau Protease Inhibitor Alzheimer Disease Program

Merck KGaA Sitting Out M&A Dance to Focus Instead on Cuts, Pipeline

Acorda Eyes Additions to Neurodegenerative Disease Drug Pipeline

Alder Scores $38M to Be Used for Its Two Clinical-Stage mAb Therapeutics

Marketwire - Pharma and Biotech
Insception Cord Blood Program Expands to Vancouver

SRS EHR Chosen Over Hospital-Subsidized EHR by Lakeside Orthopedics

FREE Arbour Report(SM), Southeast Asia Series: Regulatory Requirements for Life Sciences Companies - Malaysia

Battelle Scientists Identify Potential Early Biomarker for Autism Spectrum Disorder

Persistent Systems Revenue Crosses Rs 1,000 Crore; Annual Growth of 28.9% in Revenues and 46.8% in EBIDTA

MassBio News
10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

10 reasons to attend bio international convention

Medical Pharma - PR Newswire
Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDI's Planned Offering of Personalized Medicine Clinical Diagnostic Services

Andrew Snyder, M.D., Joins Brown & Toland Physicians as Chief Medical Officer

Dr. Dana Goldberg Announces New Office

Sandoz Enters Local Cameroon Production Partnership to Increase Access to Quality Medicines in Sub-Saharan Africa

ALS TDI Tri-State Trek Celebrates 10th Anniversary

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
Use of genome-wide association studies for drug repositioning

The art of the alliance

Addgene provides an open forum for plasmid sharing

Tensha Therapeutics

Positive signals from Washington

New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge

New York Times- Pharmaceuticals
The Wrong Way to Stop Fake Drugs

Nebraska: State Will Not Surrender Execution Drug

How Psychedelic Drugs Can Help Patients Face Death

Punjab in the Tight Grip of Addiction

Drug Collaboration Lags on Hepatitis Treatment

OnBioVC
CytoPherx, Inc.: Series C $34M

MedGenesis Therapeutix, Inc.: Series C $5M

Natura, Inc.: Series D $20M

Pulse Therapeutics, Inc.: Series B $3.1M

3-V Biosciences, Inc.: Series C $20M

Outsourcing-Pharma
Pharmas must give patients voice says DIA Europe director

Improve patient compliance by designing trials around real life, says expert

People special: social media gets job hunters noticed

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

Catalent eyes emerging market expansion of end-to-end development service model

Pharma News - Business Wire
U.S. Retinal Specialists Report That Dosing Convenience Continues to Drive Regeneron's Eylea Share Growth in the Wet AMD Market Three Months after Launch, According to a Recent BioTrends Report

Lundbeck Launches Website to Inspire and Engage the Epilepsy Community

CytRx Receives NASDAQ Extension

Quintiles Names Tom Pike CEO

InSite Vision to Report First Quarter 2012 Financial Results on May 1, 2012

Pharma News - PharmiWeb
HealthPlanOne Unveils Its Free Proprietary Mobile Quoting Tool for Medicare & Health Insurance Agents

Gulf doctors honoured at the 2012 Middle East OTO Awards

Scientific Skin by Kenneth Beer MD Launches Balancing Toner

RSA Interims celebrates 10 years of providing Interim Managers to the life sciences industry

Health Discovery Corporation's Popular MelApp Featured in Men's Health Magazine

Pharma News - PR Newswire
Asubio Initiates Landmark Clinical Study in Spinal Cord Injury

Ultragenyx Relocates Company Headquarters to Support Operational Expansion

Delcath Systems, Inc. Secures $20 Million Credit Facility

MicuRx Pharmaceuticals Completes Phase 1 Trial For MRX-I, A Next-Generation Antibiotic

Dr. Mukesh Batra Awarded Padma Shri for Medicine

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

PRWeb - Biotechnology
Dr. Mark Rizzone Receives Brewer Award

Health Care Thought Leaders Release Research Report Finding Automation...

Dr. Christine Brown Now Offers Encore CO2 Fractional Laser Therapy

5AM Solutions Announces Release of Updated CONNECT Gateway for the...

Webinar Announcement: Metabolomics as a Tool for Predictive Toxicology

PRWeb - Pharmaceuticals
invivodata Concludes Successful Annual Conference

Divine Dermatology, Now Offering The Latest Photodynamic Cosmetic...

Increasing Number of HSV Cases to Drive Global Herpes Simplex Virus...

Big Mountain Drugs Offers Tips and Coupons for Spring Asthma Sufferers

Study Shows Promise for Topical Application of Living Skin Cells...

Scientific American
Cheap Fracked Gas Could Help Americans Keep on Truckin'

Second Wind: Air-Breathing Lithium Batteries Promise Recharge-Free Long-Range Driving--If the Bugs Can Be Worked Out

Hot Spring Yields New Hybrid Viral Genome

BFF: Cell Phone Study Shows Evolving Lifetime Relationships in Men and Women

The Rue Age: Older Adults Disengage from Regrets, Young People Fixate on Them

Sports - ESPN Basketball
Arizona's Perry faces domestic violence charge

UConn's Calhoun upbeat amid transfer reports

O'Neil: Understanding why Larry Brown wants back in

King: Martin confident he can transform South Carolina into a winner

NC State makes Lutz an associate head coach

Sports News - ESPN
Penn State to host FBS newcomer UMass in '14

Report: Paternos rejected stadium naming deal

FAU, Miami announce 3-game football series

Meyer shows hurry-up offense at Ohio State

Arkansas QB: Team blindsided by Petrino affair

Xconomy Life Sciences
Amazon's Fight Against Content Middlemen: Books, TV, Movies, Games

What Are the Hottest Targets in Biotech Today

San Diego's Q1 Venture Activity Surges on One Mega Deal

Dyax, Adimab, Mersana, & More Boston Life Sciences Newsmakers

CEO Changes in Planned Succession at San Diego's Sapphire Energy

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)